A client has a gastrotomy tube in place. The health care provider ordered the medication p.o. Which action would be appropriate for the nurse to take?
Clarify the order with the charge nurse
Dilute the medication and administer by GT
Clarify the order with the health provider who wrote the order
Administer p.o as ordered
The Correct Answer is C
a) Clarifying the order with the charge nurse is not the correct action. The charge nurse may not be able to clarify medication orders and is not the primary contact for this issue.
b) Diluting and administering the medication by gastrostomy tube (GT) is inappropriate because the medication is ordered to be taken p.o. (by mouth), not via the tube.
c) Clarifying the order with the healthcare provider is the most appropriate step. A p.o. order is typically for oral administration, but the client has a gastrotomy tube. The nurse should clarify with the provider whether the medication can be crushed and administered via the tube or if a different route or medication form is necessary.
d) Administering the medication p.o. as ordered would not be appropriate if the client is unable to take oral medications. The nurse should verify the appropriate route of administration based on the patient's condition.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
a) While men and women may metabolize drugs differently, this is not the primary reason why women are often excluded from Phase I drug trials.
b) Women are not necessarily more prone to adverse effects, but concerns about fetal exposure and reproductive risks have historically limited women's participation in early trials.
c) This statement is incorrect and misleading. Drug trials are not based on strength but rather on safety, ethical concerns, and risk of reproductive harm.
d) Phase I studies test drugs on healthy volunteers, and historically, women of childbearing age were excluded due to concerns about potential teratogenic effects and unknown risks to a developing fetus. Although regulations have changed, caution is still exercised when including women in early-stage drug trials.
Correct Answer is A
Explanation
A. Bioavailability refers to the proportion of a drug that enters systemic circulation and is available for therapeutic effect. Generic drugs must demonstrate bioequivalence to brand-name drugs, meaning their bioavailability must be within an acceptable range to ensure similar efficacy.
B. Critical concentration is the minimum drug level required to produce a therapeutic effect, but it is not the primary factor in generic drug substitution.
C. Distribution refers to how a drug is transported in the body after absorption, but it is not the main concern when substituting generic drugs.
D. Half-life is the time required for the drug concentration to decrease by half in the body, but it does not determine whether a generic drug can replace a brand-name drug. Bioavailability is the key factor in ensuring therapeutic equivalence.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.